leisure time -WSS

leisure time

author：hotspot 2025-09-30 15:15:15 - browse：7

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： UpToDate has a racism problem: Dr. Stanley Goldfarb

WSS

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Childbirth

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Lupron, used to halt puberty in children, may cause lasting health problems

How Robert F. Kennedy Jr. distorted vaccine science

Fatty liver disease was alleviated by Lilly’s ‘triple

entertainment

leisure time

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

STAT wants to know your pick for a great summer read or listen

What does generative AI mean for health care? We asked experts

STAT wants to know your pick for a great summer read or listen

Wildfire smoke exposes gaps in outdoor worker protections

David Sabatini, ex

Medicare details structure of new drug price negotiation program

AI used to predict Covid

Hollywood unions extend contract negotiations for actors

Startling documents reveal new facets of Sacklers' opioid empire

hotspot

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Childbirth

A letter from the executive editor: The 2023 STATUS List

How Robert F. Kennedy Jr. distorted vaccine science

Security flaws in third

David Sabatini, ex

leisure time

knowledge

explore

explore